Mechanistically, Pontin amplified TGFβR2 gene transcription by recruiting LEF1, thereby activating TGFβ/SMAD signalling and contributing to GBM malignancy (Fig. 9). The gene discussed is RUVBL1; the disease is glioblastoma.